Cleared Traditional

PAUL SMITH SPECTACLES LTD. BY OLIVER PEOPLES, INC. (K942348) - FDA 510(k) Clearance

Class I Ophthalmic device.

K942348 · Oliver Peoples, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1994
Decision
56d
Days
Class 1
Risk

K942348 is an FDA 510(k) clearance for the PAUL SMITH SPECTACLES LTD. BY OLIVER PEOPLES, INC.. Classified as Frame, Spectacle (product code HQZ), Class I - General Controls.

Submitted by Oliver Peoples, Inc. (Los Angeles, US). The FDA issued a Cleared decision on July 12, 1994 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5842 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oliver Peoples, Inc. devices

Submission Details

510(k) Number K942348 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 1994
Decision Date July 12, 1994
Days to Decision 56 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 110d · This submission: 56d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HQZ Frame, Spectacle
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.5842
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.